U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 2,963 records

Showing results for "therapeutic".

  1. Final Progress Report: Enhanced Patient Safety Intervention to Optimize Medical (EPITOME) (pdf file)

    www.ahrq.gov/sites/default/files/2024-01/sirio-report.pdf
    January 01, 2024 - be detrimental to patient recovery and often leads to adverse complications, including inadequate treatment … These groups consisted of individuals representing respiratory therapy (for inhalation therapy); the … referral to informed pharmacists or respiratory therapists with expertise in medication and/or inhalation therapies … Critical Care Medicine, Medicine, and Surgery) and School of Pharmacy (Department of Pharmacy and Therapeutics … Similarly, upon receipt of a new medication order or therapeutic substitution, as standard of care,

  2. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/848108/psn-pdf
    April 26, 2023 - facilitate amnesia or decreased awareness and/or patient comfort and safety during a diagnostic or therapeutic … Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic … Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic

  3. Pre-COVID-19 Retail Use and Expenditures for Drugs That Were Subsequently Used to Treat COVID-19 (pdf file)

    meps.ahrq.gov/data_files/publications/rf49/rf49.pdf
    December 04, 2020 - Information for Clinicians on Investigational Therapeutics for Patients with COVID-19. … Updated December 4, 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html … A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. … SARS-CoV-2: Recent reports on antiviral therapies based on lopinavir/ritonavir, darunavir/umifenovir … Phamacologic treatments for coronavirus disease 2019 (COVID-19): A review.

  4. Methods Guide for Medical Test Reviews Chapter 2 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-topics_methods.pdf
    July 01, 2012 - Such a situation, which is not acceptable in the basic sciences or in drug therapy, also should not … However, systematic reviews of medical tests present unique challenge not encountered in reviews of therapeutic … Is there heterogeneity of test accuracy and treatment effect (i.e., do accuracy and treatment effects … domains or phases, including technical efficacy, diagnostic accuracy, diagnostic thinking efficacy, therapeutic … The tree exercise also indicated that one key question must be whether HER2-targeted therapy is effective

  5. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49716/psn-pdf
    August 21, 2014 - The Commentary Vascular access is a cornerstone of modern medical therapeutics. … Placing a vascular access device directly into the marrow cavity for medical treatment dates as far back … as the 1920s.(1) These devices were used during World War II for the treatment of shock (2), but later

  6. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
    January 01, 2007 - Among the many choices in antihypertensive therapy, some of the most common are those aimed at affecting … Therapies aimed at modifying the renin system have been used extensively for treatment of hypertension … Currently, therapies fall into one of two classes of angiotensin antagonists: the angiotensin-converting … Rates of continuation with therapy appear to be somewhat better with ARBs than with ACEIs; however, … gain more precise understanding of the impact of cough on quality of life, care patterns (e.g., use of therapeutic

  7. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49707/psn-pdf
    April 01, 2014 - One week of appropriate H. pylori treatment resulted in no improvement in symptoms; in fact, the patient … Consequently, the risks associated with ARV "polypharmacy" are compounded by the treatments associated … The Helicobacter pylori treatment presumably included clarithromycin, and this antibiotic CYP3A4 inhibitor … In addition, practicing medicine unaware of therapies given by a patient's other providers negates the … Formally communicate and review your therapeutic measures with both patients and your colleagues.

  8. Meeting Minutes, July 2022 | Agency for Healthcare Research and Quality

    www.ahrq.gov/news/events/nac/2022-07-nac/nacmtg072122-minutes.html
    December 01, 2022 - Yu emphasized the importance of integrated care and team care and said that evidence-based treatments … Buntin suggested that the future will be one of more home-based care, both diagnostic and therapeutic … Sarma mentioned a company that deals in metabolics and obesity therapeutics that is involved in addressing

  9. Arthritis-Knee-Physical-Therapy Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_executive.pdf
    November 01, 2012 - .7,8 Optimal OA management combines pharmacologic treatments with physical therapy interventions7- … , activity level, occupation Physical therapy, dose, intensity Adverse effects of treatments (any … Therapeutic Taping. … Clinical Importance of Treatment Effects With Physical Therapy Interventions. … Future RCTs should examine comparative effectiveness of combined physical therapy treatments.

  10. Diuretics and Electrolyte Abnormalities | PSNet

    psnet.ahrq.gov/web-mm/diuretics-and-electrolyte-abnormalities
    February 15, 2017 - The hyponatremia that is occasionally observed under treatment with loop diuretics is usually due to … However, the patient should be monitored closely, and diuretic treatment should be stopped if weight … Nevertheless, thiazide diuretics remain a valuable therapeutic option in treating hypertension, and most … For the treatment of hypertension, 12.5 mg to 25 mg doses are recommended. … These measures include using low starting doses and intensified monitoring around the time of treatment

  11. 2007 HCUP Nationwide Inpatient Sample (NIS) Comparison Report

    hcup-us.ahrq.gov/db/nation/nis/reports/2007niscomparisonrpt.jsp
    May 01, 2016 - 20.81% 21.58% Transplant Services 2 7.25% 7.76% Intensity Modulated Ray Radiation Therapy … 140 $8,210 141,680 Repair of current obstetric laceration 146 $42,567 53,409 Treatment … resection 287 (7) 250* (14) 9.77 (0.08) 9.43 (0.79) 3.72 (0.10) 2.90** (0.24) 146: Treatment … 26,970 Diagnostic ultrasound of heart (echocardiogram) 213 $28,718 18,822 Physical therapy … 0.70* 11.75 (0.29) 12.28 3.86 (0.20) 4.15 $55,523 (2,032) $56,069 213: Physical therapy

  12. Microsoft Word - deliverable45_2.doc (pdf file)

    hcup-us.ahrq.gov/reports/methods/2010_03.pdf
    January 01, 2010 - transfusion 228 $5,156 199,108 Prophylactic vaccinations and inoculations 231 $23,007 122,996 Other therapeutic … PTCA) 668 (36) 557* (28) 2.70 (0.04) 2.72 (0.21) 0.80 (0.03) 0.70 (0.05) 231: Other therapeutic … burn 193 $27,096 26,970 Diagnostic ultrasound of heart (echocardiogram) 213 $28,718 18,822 Physical therapy … intubation and mechanical ventilation 222 $27,574 86,521 Blood transfusion 231 $26,456 43,363 Other therapeutic … 0.66 (0.01) 0.70* 11.75 (0.29) 12.28 3.86 (0.20) 4.15 $55,523 (2,032) $56,069 213: Physical therapy

  13. Archived: Evidence Summary: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
    January 10, 2017 - Main Outcomes and Measures: Neural tube defects, harms of treatment (twinning, respiratory outcomes) … Nations Human Development Index. 3 Studies were included that compared interventions with placebo, no treatment … Do the benefits of folic acid supplementation differ by dosage, timing, or duration of therapy? … Do the harms of folic acid supplementation differ by dosage, timing, or duration of therapy? … Do the benefits of folic acid supplementation differ by dosage, timing, or duration of therapy?

  14. Citrate Mix-Up | PSNet

    psnet.ahrq.gov/web-mm/citrate-mix
    February 01, 2010 - and chronic renal failure was transferred from a skilled nursing facility (SNF) to the hospital for treatment … This error led to increased patient monitoring and drug treatment to normalize the serum potassium and … The formulary review process of the Pharmacy and Therapeutics Committee can be a forum to discuss limiting … The hospital's Pharmacy and Therapeutics Committee can develop prescribing guidelines for using these … citrate agents that inform staff of their differences and suggest therapeutic alternatives.

  15. Use of hepatotoxic drugs in chronic liver disease. | Digital Healthcare Research

    digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-4
    January 01, 2023 - , David Project Name Health Information Technology Center for Education and Research on Therapeutics

  16. Human factors considerations for contraindication alerts. | Digital Healthcare Research

    digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/human-factors-considerations-for-contraindication-alerts
    January 01, 2023 - , David Project Name Health Information Technology Center for Education and Research on Therapeutics

  17. National patient safety initiatives: moving beyond what is necessary. | Digital Healthcare Research

    digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics/citation/initiative
    January 01, 2023 - , David Project Name Health Information Technology Center for Education and Research on Therapeutics

  18. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33921/psn-pdf
    October 10, 2018 - connection to existing hospital infrastructure designed with overlapping goals (e.g., Pharmacy and Therapeutics

  19. AHRQ Slide Template 2004 (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/introduction.ppt
    January 01, 2010 - If patients are choosing between two treatments, CE research does not study treatment 1 versus placebo … but rather compares treatment 1 versus treatment 2. … Anderson Cancer Center and Baylor College of Medicine Therapies for heart and blood vessel disorders … use and resistance — University of Pennsylvania School of Medicine Therapeutic medical devices — Weill … New Jersey Therapies for older adults and the effects of aging — University of Iowa Pediatric therapeutics

  20. AHRQ Slide Template 2004 (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/introduction.ppt
    January 01, 2010 - If patients are choosing between two treatments, CE research does not study treatment 1 versus placebo … but rather compares treatment 1 versus treatment 2. … Anderson Cancer Center and Baylor College of Medicine Therapies for heart and blood vessel disorders … use and resistance — University of Pennsylvania School of Medicine Therapeutic medical devices — Weill … New Jersey Therapies for older adults and the effects of aging — University of Iowa Pediatric therapeutics
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

effectivehealthcare.ahrq.gov (768)

psnet.ahrq.gov (690)

hcup-us.ahrq.gov (523)

www.ahrq.gov (437)

digital.ahrq.gov (313)

www.uspreventiveservicestaskforce.org (145)

meps.ahrq.gov (40)

integrationacademy.ahrq.gov (31)

cdsic.ahrq.gov (6)

datatools.ahrq.gov (6)

cds.ahrq.gov (3)

qualityindicators.ahrq.gov (1)